Clinical Trials
84 trialsTTBF
University of California, San Francisco
VERDI
Dana-Farber Cancer Institute
LEARN
University of Sydney
Brodalumab in the Treatment of Immune-Related Adverse Events
Columbia University
iCaRe2
University of Nebraska
Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Memorial Sloan Kettering Cancer Center
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
NeuroPrevPTSD
Centre Oscar Lambret
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
EBNK-ST-001
Essen Biotech
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Memorial Sloan Kettering Cancer Center
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
UNC Lineberger Comprehensive Cancer Center
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Palo Alto Veterans Institute for Research
IMPLICATION
Centre Hospitalier Universitaire de Besancon
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
LIBERATE
University Health Network, Toronto
Stereotactic Magnetic Resonance Guided Radiation Therapy
Dana-Farber Cancer Institute
AYAConnect
UNC Lineberger Comprehensive Cancer Center
CALM: Managing Distress in Malignant Brain Cancer
Virginia Commonwealth University
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Hadassah Medical Organization
EARN
Washington University School of Medicine
(3D) Ultrasound Imaging Liver and Kidney
Western University, Canada
PRIORITY
Institut Bergonié
AMPLIFY
University of Alabama at Birmingham
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Chinese University of Hong Kong
Genomic Testing and Resulting Medical Decisions
Arbeitsgemeinschaft medikamentoese Tumortherapie
RespEcran
Centre Georges Francois Leclerc
MOHCCN-O
University Health Network, Toronto
HERO
Rutgers, The State University of New Jersey
Proteomic Analysis of Patients Undergoing Bariatric Surgery
Universidade Federal de Pernambuco
A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona
University of Arizona
SkinHealth
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
GI Organ Tracking Via Balloon Applicators
Washington University School of Medicine
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Cedars-Sinai Medical Center
REGATA
N.N. Petrov National Medical Research Center of Oncology
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
Sun Yat-sen University
Microwave Ablation for Treatment of Small Renal Tumors and Primary and Secondary Liver Neoplasms
IRCCS San Raffaele
ASPIRE
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Ask Questions (ASQ):Implementation of a Communication Intervention
Barbara Ann Karmanos Cancer Institute
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer
Roswell Park Cancer Institute
SPACE2
Weprom
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Weill Medical College of Cornell University
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
RenJi Hospital
ONCOPRO
Hospices Civils de Lyon
DC-CIK
Sun Yat-sen University
Study of Pre-operative Combination Therapy With Mogamulizumab and Nivolumab Against Solid Cancer Patients
Osaka University